Fig. 3From: Safety assessment of sorafenib in Chinese patients with unresectable hepatocellular carcinoma: subgroup analysis of the GIDEON studyKaplan-Meier curve survival for patients with unresectable HCC based on Child-Pugh score in the intention-to-treat population. a Overall survival (OS); (b) progression-free survival (PFS); (c) time-to-progression for Child-Pugh A versus Child-Pugh B, Child-Pugh C as defined by Response Evaluation Criteria in Solid Tumors criteriaBack to article page